Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | NUVB |
---|---|---|
09:32 ET | 6099 | 3.28 |
09:36 ET | 4841 | 3.29 |
09:38 ET | 2849 | 3.335 |
09:39 ET | 3015 | 3.35 |
09:41 ET | 3048 | 3.33 |
09:43 ET | 750 | 3.32 |
09:45 ET | 2818 | 3.32 |
09:48 ET | 3040 | 3.32 |
09:50 ET | 1436 | 3.315 |
09:52 ET | 100 | 3.32 |
09:56 ET | 2070 | 3.305 |
09:57 ET | 2507 | 3.3009 |
09:59 ET | 2351 | 3.315 |
10:01 ET | 1319 | 3.305 |
10:03 ET | 2400 | 3.305 |
10:06 ET | 1000 | 3.31 |
10:08 ET | 1931 | 3.315 |
10:10 ET | 700 | 3.315 |
10:12 ET | 5780 | 3.335 |
10:14 ET | 300 | 3.34 |
10:15 ET | 1100 | 3.34 |
10:17 ET | 400 | 3.335 |
10:19 ET | 5975 | 3.33 |
10:21 ET | 2449 | 3.34 |
10:24 ET | 1994 | 3.35 |
10:26 ET | 4192 | 3.35 |
10:28 ET | 3380 | 3.36 |
10:30 ET | 9990 | 3.38 |
10:32 ET | 4471 | 3.375 |
10:33 ET | 4307 | 3.375 |
10:35 ET | 6812 | 3.36 |
10:37 ET | 400 | 3.36 |
10:39 ET | 1992 | 3.365 |
10:42 ET | 15210 | 3.3301 |
10:44 ET | 840 | 3.335 |
10:46 ET | 700 | 3.335 |
10:48 ET | 2633 | 3.325 |
10:50 ET | 950 | 3.335 |
10:51 ET | 606 | 3.33 |
10:53 ET | 11006 | 3.33 |
10:55 ET | 500 | 3.33 |
10:57 ET | 226 | 3.325 |
11:00 ET | 3005 | 3.34 |
11:02 ET | 400 | 3.345 |
11:04 ET | 432 | 3.345 |
11:06 ET | 1100 | 3.3471 |
11:08 ET | 1200 | 3.36 |
11:09 ET | 3283 | 3.36 |
11:11 ET | 2300 | 3.365 |
11:13 ET | 2500 | 3.365 |
11:15 ET | 100 | 3.363 |
11:18 ET | 4787 | 3.36 |
11:20 ET | 200 | 3.36 |
11:22 ET | 18746 | 3.385 |
11:24 ET | 5244 | 3.39 |
11:26 ET | 3012 | 3.39 |
11:27 ET | 5325 | 3.38 |
11:29 ET | 30522 | 3.375 |
11:31 ET | 434 | 3.36 |
11:33 ET | 1700 | 3.34 |
11:38 ET | 200 | 3.345 |
11:40 ET | 300 | 3.345 |
11:42 ET | 2100 | 3.36 |
11:44 ET | 15701 | 3.36 |
11:45 ET | 500 | 3.37 |
11:47 ET | 11524 | 3.355 |
11:49 ET | 307 | 3.3569 |
11:51 ET | 100 | 3.355 |
11:54 ET | 650 | 3.355 |
11:56 ET | 1200 | 3.36 |
11:58 ET | 200 | 3.36 |
12:00 ET | 200 | 3.36 |
12:02 ET | 300 | 3.36 |
12:03 ET | 200 | 3.355 |
12:05 ET | 2120 | 3.36 |
12:07 ET | 2064 | 3.354 |
12:09 ET | 300 | 3.355 |
12:12 ET | 3299 | 3.345 |
12:14 ET | 2097 | 3.33 |
12:16 ET | 100 | 3.335 |
12:18 ET | 100 | 3.335 |
12:20 ET | 1075 | 3.335 |
12:21 ET | 236 | 3.335 |
12:23 ET | 200 | 3.33 |
12:27 ET | 200 | 3.335 |
12:30 ET | 1560 | 3.32 |
12:32 ET | 100 | 3.3299 |
12:34 ET | 9890 | 3.335 |
12:36 ET | 343 | 3.335 |
12:39 ET | 200 | 3.335 |
12:41 ET | 618 | 3.335 |
12:43 ET | 3762 | 3.34 |
12:45 ET | 445 | 3.335 |
12:48 ET | 2300 | 3.345 |
12:50 ET | 309 | 3.345 |
12:52 ET | 200 | 3.345 |
12:54 ET | 200 | 3.35 |
12:56 ET | 2467 | 3.345 |
12:57 ET | 100 | 3.35 |
12:59 ET | 200 | 3.35 |
01:01 ET | 6758 | 3.33 |
01:03 ET | 2696 | 3.315 |
01:06 ET | 710 | 3.32 |
01:08 ET | 100 | 3.32 |
01:12 ET | 10476 | 3.315 |
01:14 ET | 2548 | 3.325 |
01:15 ET | 534 | 3.325 |
01:17 ET | 540 | 3.33 |
01:19 ET | 4916 | 3.33 |
01:26 ET | 4253 | 3.325 |
01:28 ET | 10000 | 3.32 |
01:30 ET | 330 | 3.325 |
01:32 ET | 200 | 3.33 |
01:33 ET | 200 | 3.325 |
01:35 ET | 5112 | 3.315 |
01:37 ET | 2704 | 3.3102 |
01:39 ET | 4075 | 3.3111 |
01:42 ET | 462 | 3.315 |
01:44 ET | 400 | 3.32 |
01:46 ET | 1100 | 3.32 |
01:48 ET | 3839 | 3.315 |
01:50 ET | 1804 | 3.315 |
01:51 ET | 100 | 3.32 |
01:53 ET | 200 | 3.32 |
01:55 ET | 300 | 3.32 |
01:57 ET | 5547 | 3.32 |
02:02 ET | 3113 | 3.315 |
02:04 ET | 100 | 3.315 |
02:06 ET | 200 | 3.32 |
02:08 ET | 355 | 3.32 |
02:09 ET | 300 | 3.32 |
02:13 ET | 200 | 3.315 |
02:15 ET | 300 | 3.32 |
02:18 ET | 100 | 3.315 |
02:20 ET | 200 | 3.32 |
02:22 ET | 108 | 3.315 |
02:24 ET | 300 | 3.32 |
02:26 ET | 250 | 3.315 |
02:27 ET | 100 | 3.315 |
02:29 ET | 300 | 3.32 |
02:31 ET | 200 | 3.315 |
02:33 ET | 400 | 3.32 |
02:36 ET | 500 | 3.32 |
02:38 ET | 100 | 3.3238 |
02:40 ET | 354 | 3.325 |
02:42 ET | 300 | 3.325 |
02:44 ET | 100 | 3.325 |
02:45 ET | 1928 | 3.325 |
02:47 ET | 2527 | 3.34 |
02:51 ET | 5400 | 3.34 |
02:54 ET | 1132 | 3.345 |
02:56 ET | 500 | 3.35 |
02:58 ET | 19643 | 3.355 |
03:00 ET | 5112 | 3.345 |
03:02 ET | 1050 | 3.345 |
03:03 ET | 1861 | 3.344 |
03:05 ET | 600 | 3.345 |
03:07 ET | 2500 | 3.345 |
03:09 ET | 100 | 3.34 |
03:12 ET | 300 | 3.345 |
03:14 ET | 200 | 3.345 |
03:16 ET | 10703 | 3.35 |
03:18 ET | 4400 | 3.355 |
03:20 ET | 200 | 3.36 |
03:21 ET | 7075 | 3.345 |
03:25 ET | 9120 | 3.345 |
03:27 ET | 13642 | 3.355 |
03:32 ET | 400 | 3.355 |
03:34 ET | 700 | 3.355 |
03:36 ET | 617 | 3.355 |
03:38 ET | 14186 | 3.355 |
03:39 ET | 6410 | 3.345 |
03:41 ET | 1646 | 3.3425 |
03:43 ET | 3544 | 3.355 |
03:45 ET | 6347 | 3.355 |
03:48 ET | 701 | 3.355 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Nuvation Bio Inc | 801.8M | -9.7x | --- |
Longboard Pharmaceuticals Inc | 782.3M | -8.8x | --- |
ALX Oncology Holdings Inc | 844.5M | -4.2x | --- |
ARS Pharmaceuticals Inc | 846.9M | -15.6x | --- |
Praxis Precision Medicines Inc | 834.5M | -1.9x | --- |
Mesoblast Ltd | 804.9M | -4.9x | --- |
Nuvation Bio Inc. is a biopharmaceutical company. The Company is engaged in tackling the unmet needs in oncology by developing differentiated and therapeutic candidates. The Company is advancing multiple clinical-stage candidates, including a ROS1 inhibitor, a mutant isocitrate dehydrogenase 1 (mIDH1) inhibitor, a bromodomain and extra-terminal (BET) inhibitor, and a drug-drug conjugate (DDC). Its portfolio of development candidates includes taletrectinib (ROS1), safusidenib (mIDH1), NUV-868 (BET), and NUV-1511 (DDC). Taletrectinib is an oral, potent, CNS-active, selective, ROS1 inhibitor specifically designed for the potential treatment of ROS1-positive non-small cell lung cancer (NSCLC). Safusidenib is an oral, potent, targeted inhibitor of mIDH1 being evaluated in a global Phase II trial in patients with low-grade IDH1-mutant glioma. NUV-868 is a BD2-selective oral small molecule BET inhibitor, that inhibits BRD4. It is conducting Phase I/II study of NUV-1511.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $801.8M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 246.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.44 |
EPS | $-0.35 |
Book Value | $2.76 |
P/E Ratio | -9.7x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.